DNA methylation in states of cell physiology and pathology

Folia Histochemica et Cytobiologica

Volumn 45, Issue 3, 2007, Pages 149-158

  Sulewska, Anetta ^a   Niklińska, Wiesława ^a   Kozłowski, Mirosław ^a   Minarowski, Łukasz ^a   Naumnik, Wojciech ^a   Nikliński, Jacek ^a   Dabrowska, Katarzyna ^a   Chyczewski, Lech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

"Non CpG" methylation; DNA hypermethylation; DNA hypomethylation; DNA methyltransferases

Indexed keywords

5 METHYLCYTOSINE; DINUCLEOTIDE; DNA; DNA METHYLTRANSFERASE; PROTEIN P53; THYMINE; TUMOR MARKER;

AGING; AMINO ACID SUBSTITUTION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL METABOLISM; CHROMOSOMAL INSTABILITY; CPG ISLAND; CYTOPATHOLOGY; DEMETHYLATION; DNA HYPERMETHYLATION; DNA HYPOMETHYLATION; DNA METABOLISM; DNA METHYLATION; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION REGULATION; GENE LOCATION; GENE SILENCING; GENOME IMPRINTING; HETEROZYGOSITY LOSS; HUMAN; LUNG NON SMALL CELL CANCER; NONHUMAN; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; TISSUE DIFFERENTIATION; X CHROMOSOME;

EID: 35548968386     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Garcia RN, D'Avila MF, Robe LJ, Loreto EL, Panzera Y, de Heredia FO, Yalente VL. First evidence of methylation in the genome of Drosophila willistoni. Genetica. 2007;131:91-105.
2. Kilgore JA, Hoose SA, Gustafson TL, Porter W, Kladde MP. Single-molecule and population probing of chromatin structure using DNA methyltransferases. Methods. 2007;41:320-32.
3. Yu MC, Lamming DW, Eskin JA, Sinclair DA, Silver PA. The role of protein arginine methylation in the formation of silent chromatin. Genes Dev. 2006;20:3249-3254.
4. Zilberman D, Gehring M, Tran RK, Ballinger T, Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet. 2007;39:61-69.
5. Arney KL, Fisher AG. Epigenetic aspects of differentiation. J Celi Sci. 2004;117:4355-4363.
6. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis epigenetics joins genetics. Trends Genet. 2000;16:168-174.
7. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6-21.
8. Gopisetty G, Ramachandran K, Singal R. DNA methylation and apoptosis. Mol Immunol. 2006;43:1729-1740.
9. Herman JG. Baylin SB. Gene silencing in cancer is association with promoter hypermethylation. N Eng J Med. 2003;349:2042-2054.
10. Jones PA. DNA methylation and cancer. Aaronson SA, Borst P, Brentani RR, Chaganti R, Cohen JS, et al., editiorial directors; Bertino JR, ed-in-chief. Encyclopedia of cancer. Vol 1. San Diego. London, Boston, New York, Sydney, Tokyo, Toronto. Academic Press; 1997:501-507.
11. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006;31:89-97.
12. Liu Z-J, Maekawa M. Polymerase chain reaction-based methods of DNA methylation analysis. Anal Biochem. 2003;317:259-265.
13. Panani AD, Roussos C. Cytogenetic and molecular aspects of lung cancer. Cancer Lett. 2006;239:1-9.
14. Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hot B, Prinsen C, Thunnissen FB, Gazdar AF. Application of methylation gene panel by quantitative PCR for lung cancer. Cancer Lett. 2007;247:56-71.
15. Caiafa P, Zampieri M. DNA methylation and chromatin structure: The puzzling CpG islands. J Cell Biochem. 2005;94:257-265.
16. Chen L, MacMillan AM, Chang W, Ezaz-Nikpay K, Lane WS, Yerdine GL. Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. Biochemistry. 1991;30:11018-11025.
17. Okano M, Li E. Methyltransferases of DNA. Kazazian HH, Klein G, Moser HW, Orkin SH, Roizman B, Thakker RV, Watkins H. Wiley Encyclopedia of Molecular Medicine. Vol. 3. New York, A Wiley-Interscience Publication. John Wiley &Sons, Inc; 2002:2073-2076.
18. Debby MEI, Griffioen AW, Hellebrekers DM, Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta. 2007;1775:76-91.
19. Fryxell KJ, Zuckerkandl E. Cytosine deamination plays a primary role in the evolution of mammalian isochores. Mol Biol Evol. 2000;17:1371-1383.
20. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim et Biophys Acta. 2007;1775:138-162.
21. van Driel R, Fransz PF, Yerschure PJ. The eukaryotic genome: a system regulated at different hierarchical levels. J Cell Sci. 2003;116:4067-4075.
22. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol. 2000;249:101-118.
23. Richardson B. Impact of aging on DNA methylation. Ageing Res Rev. 2003;2:245-261.
24. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:254-254.
25. Chen T, Tsujimoto N, Li E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol Cell Biol. 2004;24:9048-9058.
26. Kim SH, Park J, Choi MC, Kim HP, Park JH, Jung Y, Lee JH, Oh DY, Im SA, Bang YJ, Kim TY. Zinc-fingers and homeoboxes 1 (ZHX 1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression. Biochem Biophys Res Commun. 2007;355:318-323.
27. Majumder S, Ghoshal K, Datta J, Smith DS, Bai S, Jacob ST. Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription. J Biol Chem. 2006;281: 22062-22072.
28. Łuczak MW, Jagodzinski PP. The role of DNA methylation in cancer development. Folia Histochem et Cytobiol. 2006;44:143-154.
29. Chen ZX, Mann JR, Hsiech CL, Riggs AD, Chedin F. Phisical and functional interactions between the human DNMT3L protein and members of the de novo methyltranferase family. J Cell Biochem. 2005;95:902-917.
30. Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Peron CM, Kim YE, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLOS Medicine. 2006;2:2244-2263.
31. Leu YW, Rahmatpanah F, Shi H, Wei SH, Liu JC, Yan PS, Huang TH. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res. 2003;63:6110-6115.
32. Aranyi T, Faucheux BA, Khalfallah O, Yodjdani G, Biguet NF, Mallet J, Meloni R. The tissue-specific methylation of the human tyrosine hydroxylase gene reveals new regulatory elements in the first exon. J Neurochem. 2005;94: 129-139.
33. Sekiya T. Methyl-CpG binding protein. Kazazian HH, Klein G, Moser HW, Orkin SH, Roizman B, Thakker RV, Watkins H. Wiley Encyclopedia of Molecular Medicine. Vol 3. New York, A Wiley-Interscience Publication. John Wiley & Sons, Inc; 2002:2069-2071.
34. Allegrucci C, Thurston A, Lucas E, Young L. Epigenetics and the germline. Reproduction. 2005;129:137-149.
35. Lee JH, Hart SR, Skalnik DG. Histone deacetylase activity is reauired for embryonic stem cell differentiation. Genesis. 2004;38:32-38.
36. Szutorisz H, Canzonetta C, Georgiou A, Chow CM, Tora L, Dillon N. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol Cell Biol. 2005;25:1804-1820.
37. Lin CH, Hsieh S Y, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF. Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res. 2001;61:4238-4243.
38. Joseph B, Mamatha G, Raman G, Shanmugam MP, Kumaramanickavel G. Methylation status of RB1 promoter in Indian retinoblastoma patients. Cancer Biol Ther. 2004;3:184-187.
39. de Menezes Duarte RL, Paschoal MEM. Molecular markers in lung cancer: prognostic role and relationship to smoking. J Bras Pneumol. 2005;32:56-65.
40. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene. 1993;8:1063-1067.
41. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM. Transcriptional silencing is associated with extensive methylation od the CMV promoter following adenoviral gene delivery to muscle. J Gene Med. 2004;6:395-404.
42. Bruce JL, Hurford RK Jr, Classon M, Koh J, Dyson N. Requirements for cell cycle arrest by p16INK4a. Moll Cell. 2000;6:737-742.
43. Auerkari EI. Methylation of tumor suppressor genes p 16 (INK4a), p21 (Kip1) and E-cadherin in carcinogenesis. Oral Oncol. 2006;42:5-13.
44. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61:3225-3229.
45. Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hol B, Prinsen C, Thunnissen FB, Gazdar AF. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett. 2007;247:56-71.
46. Dodge JE, Ramsahoye BH, Wo ZG, Okano M, Li E. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene. 2002;289:41-48.
47. Shivapurkar N, Takahashi T, Reddy J, Zheng Y, Stastny V, Collins R, Toyooka S, Suzuki M, Parikh G, Asplund S, Kroft SH, Timmons C, McKenna RW, Feng Z, Gazdar AF. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res. 2004;64:3757-3760.
48. Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M. P73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2007;120:60-66.
49. Willemsen NM, Hitchen EM, Bodetti T J, Apolloni A, Warrilow D, Piller SC, Harrich D. Protein methylation is required to maintain optimal HIV-1 infectivity. Retrovirology. 2006:15;3:92.
50. Zheng Z-M, Baker CC. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci. 2006;11:2286-2302.
51. Niklinski J, Niklinska W, Laudanski J, Chyczewska E. Chyczewski L. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer 2001;34:53-38.
52. Niklinski J, Niklinska W, Chyczewski L, Chyczewska E, Laudanski J. P53 and p16 alterations in lung cancer. Chyczewski L, Niklinski J, Pluygers E. Endocrine disrupters and carcinogenic risk assessment. Series I: Life and Behavioural Sciences. Vol. 340. Amsterdam, Berlin, Oxford, Tokyo, Washington, DC, IOS Press 2000;178-187.
53. Kouidou S, Agidou T, Kyrkou A, Andreou A, Katopodi T, Georgiou E, Krikelis D, Dimitriadou A, Spanos P, Tsilikas C, Destouni H, Tzimagiorgis G. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma. Lung Cancer. 2005;50:299-307.
54. Mao L. Molecular abnormalities in lung carcinogenesis and their potential clinical implications. Lung Cancer. 2001;34: 27-34.
55. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 2003;5618:455.
56. Robertson KD. DNA Methylation in Mammalian Cells. Available at: http://www.med.ufl.edu/biochem/keithr/fig1pt1.html Accessed February 14, 2007.
57. Robertson KD. DNA Methylation and Cancer. Available at: http://www.med.ufl.edu/biochem/keithr/research.html Accessed February 14, 2007.
58. 2007 Web Book Publications. DNA Methylation and CpG Island. 1996. Available at: http://www.web-books.com/MoBio/Free/Ch7F2.htm Accessed January 4, 2007.